HLA-A and breast carcinoma: To determine whether our findings on HLA-A, -B, and -C extend beyond MDA-MB-231 cells, we examined the synaptic abundance of these molecules in MDA-MB-468 cells, a more epithelial-like and EGFR-dependent breast carcinoma cell line.